ID: ALA5272342

Max Phase: Preclinical

Molecular Formula: C17H16O3

Molecular Weight: 268.31

Associated Items:

Representations

Canonical SMILES:  CCOc1ccc(C(=O)/C=C/c2ccc(O)cc2)cc1

Standard InChI:  InChI=1S/C17H16O3/c1-2-20-16-10-6-14(7-11-16)17(19)12-5-13-3-8-15(18)9-4-13/h3-12,18H,2H2,1H3/b12-5+

Standard InChI Key:  CDHWNXIYADIGFA-LFYBBSHMSA-N

Associated Targets(Human)

Monoamine oxidase B 8835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 268.31Molecular Weight (Monoisotopic): 268.1099AlogP: 3.69#Rotatable Bonds: 5
Polar Surface Area: 46.53Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.04CX Basic pKa: CX LogP: 3.79CX LogD: 3.78
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.66Np Likeness Score: -0.09

References

1. Guglielmi P, Mathew B, Secci D, Carradori S..  (2020)  Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors.,  205  [PMID:32920430] [10.1016/j.ejmech.2020.112650]

Source